Pulmonx (LUNG) Competitors $2.90 +0.25 (+9.43%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$2.94 +0.04 (+1.38%) As of 07/11/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LUNG vs. DCTH, TMCI, OM, NPCE, CLPT, NNOX, SKIN, ZIMV, BSGM, and SNWVShould you be buying Pulmonx stock or one of its competitors? The main competitors of Pulmonx include Delcath Systems (DCTH), Treace Medical Concepts (TMCI), Outset Medical (OM), NeuroPace (NPCE), ClearPoint Neuro (CLPT), Nano-X Imaging (NNOX), Beauty Health (SKIN), ZimVie (ZIMV), Biosig Technologies (BSGM), and Sanuwave Health (SNWV). These companies are all part of the "medical equipment" industry. Pulmonx vs. Its Competitors Delcath Systems Treace Medical Concepts Outset Medical NeuroPace ClearPoint Neuro Nano-X Imaging Beauty Health ZimVie Biosig Technologies Sanuwave Health Delcath Systems (NASDAQ:DCTH) and Pulmonx (NASDAQ:LUNG) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, earnings, profitability, dividends, valuation, institutional ownership and media sentiment. Do institutionals and insiders have more ownership in DCTH or LUNG? 61.1% of Delcath Systems shares are held by institutional investors. Comparatively, 91.0% of Pulmonx shares are held by institutional investors. 17.4% of Delcath Systems shares are held by company insiders. Comparatively, 6.8% of Pulmonx shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has more volatility and risk, DCTH or LUNG? Delcath Systems has a beta of 0.87, indicating that its stock price is 13% less volatile than the S&P 500. Comparatively, Pulmonx has a beta of 0.45, indicating that its stock price is 55% less volatile than the S&P 500. Does the media prefer DCTH or LUNG? In the previous week, Pulmonx had 1 more articles in the media than Delcath Systems. MarketBeat recorded 2 mentions for Pulmonx and 1 mentions for Delcath Systems. Pulmonx's average media sentiment score of 0.74 beat Delcath Systems' score of 0.65 indicating that Pulmonx is being referred to more favorably in the news media. Company Overall Sentiment Delcath Systems Positive Pulmonx Positive Is DCTH or LUNG more profitable? Delcath Systems has a net margin of -26.38% compared to Pulmonx's net margin of -65.27%. Delcath Systems' return on equity of -29.44% beat Pulmonx's return on equity.Company Net Margins Return on Equity Return on Assets Delcath Systems-26.38% -29.44% -20.75% Pulmonx -65.27%-63.69%-34.94% Which has preferable valuation and earnings, DCTH or LUNG? Delcath Systems has higher earnings, but lower revenue than Pulmonx. Delcath Systems is trading at a lower price-to-earnings ratio than Pulmonx, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDelcath Systems$37.21M10.61-$26.39M-$0.50-22.68Pulmonx$83.79M1.39-$56.39M-$1.44-2.01 Do analysts recommend DCTH or LUNG? Delcath Systems currently has a consensus target price of $24.00, indicating a potential upside of 111.64%. Pulmonx has a consensus target price of $11.53, indicating a potential upside of 297.41%. Given Pulmonx's higher possible upside, analysts plainly believe Pulmonx is more favorable than Delcath Systems.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Delcath Systems 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Pulmonx 0 Sell rating(s) 3 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.63 SummaryDelcath Systems beats Pulmonx on 9 of the 16 factors compared between the two stocks. Get Pulmonx News Delivered to You Automatically Sign up to receive the latest news and ratings for LUNG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LUNG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LUNG vs. The Competition Export to ExcelMetricPulmonxMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$116.75M$1.95B$5.56B$9.11BDividend YieldN/AN/A5.06%4.01%P/E Ratio-2.0134.5628.2620.26Price / Sales1.3915.65435.95101.33Price / CashN/A54.0237.1257.67Price / Book1.348.368.045.49Net Income-$56.39M-$62.39M$3.19B$250.45M7 Day Performance4.50%5.08%3.62%4.78%1 Month Performance-4.29%10.63%5.98%9.58%1 Year Performance-60.92%5.72%29.39%16.41% Pulmonx Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LUNGPulmonx3.4487 of 5 stars$2.90+9.4%$11.53+297.4%-60.9%$116.75M$83.79M-2.01250High Trading VolumeDCTHDelcath Systems2.3681 of 5 stars$12.24-3.5%$24.00+96.1%+40.5%$441.94M$37.21M0.0060TMCITreace Medical Concepts2.5161 of 5 stars$6.05-2.1%$10.16+67.9%-26.1%$388.66M$209.36M0.00250OMOutset Medical1.4622 of 5 stars$20.45-2.2%$27.00+32.0%-69.2%$370.40M$113.69M0.00520Gap DownNPCENeuroPace3.4669 of 5 stars$10.22-1.6%$15.50+51.7%+28.0%$340.78M$79.91M0.00170CLPTClearPoint Neuro1.867 of 5 stars$11.80+0.9%$25.00+111.9%+51.6%$327.47M$31.39M0.00110News CoverageAnalyst DowngradeNNOXNano-X Imaging2.0001 of 5 stars$5.12-3.8%$9.50+85.5%-43.2%$307.38M$11.28M0.00190Positive NewsSKINBeauty Health0.2868 of 5 stars$2.20-3.5%$1.42-35.6%-5.0%$287.27M$334.30M0.001,030Trending NewsZIMVZimVie2.0213 of 5 stars$9.43-8.0%$16.33+73.2%-51.8%$285.43M$449.75M12.981,770BSGMBiosig Technologies1.957 of 5 stars$11.55+11.0%$10.00-13.4%+1,145.2%$284.14M$40K0.0050Gap UpHigh Trading VolumeSNWVSanuwave HealthN/A$33.17+4.8%N/AN/A$270.79M$32.63M0.0040Positive News Related Companies and Tools Related Companies Delcath Systems Competitors Treace Medical Concepts Competitors Outset Medical Competitors NeuroPace Competitors ClearPoint Neuro Competitors Nano-X Imaging Competitors Beauty Health Competitors ZimVie Competitors Biosig Technologies Competitors Sanuwave Health Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LUNG) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pulmonx Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Pulmonx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LUNG Stock Alerts